The information below is disclosed in accordance with Rule 26 of the AIM Rules for Companies and was last updated on 27 January 2023.

Business Description Please click on the link below for a description of the business.
Investor Overview
Board of Directors Please click here for names and brief biographical details of each of the directors.
Annual and Interim Reports Please click on this link to access the Company's Annual and Interim Reports.
Corporate Governance The Directors have decided to apply the 2018 Quoted Companies Alliance Corporate Governance Code (“the QCA Code”). Please click here for more detail on how the Company complies with the QCA Code, together with reasons for any departure from it.
Country of Incorporation and Main Country of Operation The Company is incorporated in England and Wales, with registered number 06227084.
Its main country of operation is , the UK, and it has operations in the USA and, Malaysia.
UK Takeover Code The Company is subject to the UK City Code on Takeovers and Mergers.
Current constitutional documents Please click on this link for access to our Key Corporate Documents, including the Company's Articles of Association.
Details of any other exchanges or trading platforms The Company’s shares are not traded on any other stock exchange.
The number of AIM securities in issue The Company does not hold any Ordinary Shares in treasury and therefore the number of Ordinary Shares with voting rights is 146,712,380.
Number of AIM securities not in public hands The percentage of AIM securities not in public hands is 36.6%
Significant shareholders The identity and percentage holdings of significant shareholders as notified to the Company:
Name of Shareholder Number of Ordinary Shares Percentage of Issued Share Capital
Odey Asset Management LLP 26,945,092 18.37%
Vulpes Life Sciences Fund 16,909,203 11.52%
Vulpes Testudo Fund 2,348,644 1.60%
Unicorn Asset Management 10,000,000 6.82%
Christian Hoyer Millar and Family 9,195,370 6.27%
Investec Wealth & Investment Ltd 7,319,886 4.99%
Alexandre Akoulitchev 6,303,082 4.30%
The Chancellor, Masters and Scholars of the University of Oxford 5,724,476 3.90%
Aroul Ramadass and Family 5,490,468 3.74%
GL Healthcare Investment L.P. 4,688,000 3.20%

Please submit TR1 notifications to investorrelations@oxfordbiodynamics.com

Significant shareholder information last updated on 27 January 2023.

Details of any restrictions on the transfer of AIM securities There are no restrictions on the transfer of the Company’s Ordinary Shares.
Regulatory notifications Please click on the link to access notifications made by the Company in the past five years.
Regulatory news
AIM admission document and circulars Please click on the link below to access the Company's most recent admission document and circulars or similar publications sent to shareholders within the past 12 months, as well as any prospectus issued since 3 January 2018.
Key Corporate Documents
Directors' responsibilities Please click here for details of the of the responsibilities of the members of the board of directors and the subcommittees of the Board.
Advisors Please click on the link below for details of the Company's Nominated Adviser and other key advisers.
Investor Contacts